Gene Query: CDCP1

Dataset Description Geneva Score
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 91.75
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 86.45
Gene Expression Profiling of SPOP Knocked Down Cell 82.94
Generation of trichogenic adipose-derived stem cells by expression of three factors 79.23
Inhibition of TNBC metastasis by Gpx1 77.99
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 77.69
Transcriptional responses of human insulinoma cells to acute cytokine exposure 75.22
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 72.11
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 72.11
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 69.08
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 69.04
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 65.78
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 65.23
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 63.53
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 60.23
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 58.67
RNA-seq of young and quiescent MRC-5 human fibroblasts 58.21
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 57.27
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 57.26
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 56.79
Differential gene expression profiles in imatinib-resistant cell lines 56.68
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 54.54
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 54.45
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 54.45
WRN knockout effects upon gene expression in SW48 and OVK18 52.71
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 52.63
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 50.78
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 50.78
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 50.15
MYCi975 regulates MYC target genes 49.47
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 49.11
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 49.07
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 47.22
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 47.09
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 46.83
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 46.74
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 46.0
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 45.34
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 44.87
RNA-seq of cells with TET1 knockout 44.41
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 44.24
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 43.74
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 43.65
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 43.27
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 43.27
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 42.9
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 41.62
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 41.62
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 41.49
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 41.23
Crizotinib v. DMSO in SW480 cells 40.98
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 40.94
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 40.37
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 40.37
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 40.09
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 39.94
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 39.61
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 39.31
Tumor exosome integrins determine organotropic metastasis 39.09
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 39.08
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 38.66
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 38.61
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 38.61
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 38.53
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 38.21
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 38.17
Nucleoporin-mediated regulation of cell identity genes 37.14
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 36.93
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 36.87
Identification of Nrf2 regulated genes by RNA sequencing 36.65
Nrf2 regulated genes in A549 cells 36.65
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 36.13
RNA-Seq analysis of breast cancer cells after shikonin treatment 36.1
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 36.04
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 36.01
Altering cancer transcriptomes using epigenomic inhibitors 35.84
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 35.84
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 35.61
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 35.61
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 35.21
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 34.26
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 34.07
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 34.01
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 33.9
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 33.86
Neurofibroma 33.83
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 33.83
Transcriptomic and gene ontology profiling of the human corneal cell types 32.7
Regulation of highly expressed hCINAP on translatome 32.55
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 32.15
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 31.79
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 31.32
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 31.2
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 31.2
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 30.87
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 30.69
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 30.27
Rorc disruption in human FG pancreatic cancer cells 30.18
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 29.97
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 29.89
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 29.86
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 29.83
U2AF1 mutations alter splice site recognition in hematological malignancies 29.83
Differential Gene Expression between MCF10A and MCF7 cells 29.83
Transcriptome analysis of virus infected tissues 29.07
RNA-seq of human aneuploid cell lines with Trisomy 21 29.02
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 28.85
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 28.51
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 28.13
Genome-wide transcriptional response to random aneuploidy in human cells 27.42
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 27.36
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 27.34
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 27.27
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 27.27
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 27.18
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 27.16
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 27.16
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 26.98
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 26.88
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 26.71
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 26.7
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 26.47
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 26.47
RNA-seq in HepG2 and IMR90 cells 26.04
Evolution of a transcriptional regulator from a transmembrane nucleoporin 26.04
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 26.03
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 26.03
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 25.97
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 25.97
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 25.81
Transcriptional effect of ETV1 knockdown in melanoma cells 25.78
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 25.68
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 25.56
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 25.51
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 25.48
6mer seed toxicity in tumour suppressive microRNAs 25.44
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 25.43
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 25.39
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 25.33
Transcriptomic profile of human embryonic renal corpuscles 25.13
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 24.91
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 24.63
Molecular Mechanisms of Endothelial Hyperpermeability 24.58
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 24.56
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 24.49
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 24.43
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 24.39
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 24.37
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 24.11
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 24.11
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 24.07
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 24.07
RNA-seq of human fibroblasts after irradiation 24.07
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 23.92
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 23.67
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 23.55
Effect of Influenza virus infection on lncRNA expression in A549 cells 23.33
Aneuploidy triggers an immune response 23.31
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 23.0
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 22.82
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 22.69
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 22.4
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 22.2
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 22.13
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 22.13
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 22.13
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 22.06
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 21.69
circRNA-sequencing 21.16
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 21.15
RNA seq_PDX2_SHP099 21.12
mRNA expression profile of Lymphocytes by high-throuput sequencing 20.94
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 20.8
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 20.53
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 20.49
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 20.47
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 20.45
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 20.45
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 20.43
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 20.43
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 20.39
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 20.12
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 20.04
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 19.96
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 19.75
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 19.71
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 19.7
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 19.65
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 19.58
Differential gene expression in Jagged1 treated human dental pulp cells. 19.56
Chromatin landscape of human visceral and subcutaneous adipocytes 19.56
CD73 knockdown effect in pancreatic cancer cell lines 19.51
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 19.26
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 19.22
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 19.15
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 19.15
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 18.97
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 18.72
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 18.69
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 18.69
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 18.66
DJ-1 is dispensable for human stem cell homeostasis 18.51
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 18.41
Role of CD133 molecule in WNT response and renal repair 18.28
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 18.21
RNA-seq analyses of human prostate cancer cells 18.17
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 18.04
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 17.71
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 17.56
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 17.56
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 17.55
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 17.5
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 17.5
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 17.42
Ribosomal footprinting of MDA-Parental and MDA-LM2 17.37
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 17.33
Hypoxic transcriptome of SQ20B human head and neck cancer cells 17.26
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 17.21
TFAP2C signalling in human fibroblasts 17.13
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 16.89
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 16.67
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 16.25
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 16.25
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 16.18
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 15.84
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 15.76
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 15.76
Gene expression profiling of human and murine in vitro muscle differentiation 15.68
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 15.59
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 15.59
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 15.57
RNA-seq of shEZH2 cells 15.36
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 15.2
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 15.06
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 15.06
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 15.02
Identification of differentially expressed genes between senescence and senescence bypass cells 15.01
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 14.91
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 14.83
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 14.82
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 14.81
RNA-seq of cancer cell lines treated with T-025 14.78
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 14.78
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 14.73
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 14.64
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 14.59
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 14.59
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 14.55
TGF-β promotes genomic instability after loss of RUNX3 14.53
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 14.53
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 14.48
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 14.48
Transcriptome profiling of 5 human adenocarcinoma cell lines 14.4
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 14.35
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 14.33
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 14.33
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 14.18
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 14.11
Ribosomal footprinting of CN34-Parental and CN34-LM1a 14.08
Epigenome regulation during epidermal lineage commitment 14.08
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 14.05
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 13.93
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 13.93
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 13.85
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 13.85
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 13.81
RNA-seq melanoma 13.51
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 13.44
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 13.32
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 13.3
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  13.26
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 13.26
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 13.24
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 13.23
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 13.2
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 13.13
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 13.1
NHLRC1 re-expression in cancer cells 13.07
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 13.0
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 12.97
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 12.95
Genome wide expression change by RNF168 knocking down in NEC cells 12.93
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 12.87
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 12.72
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 12.7
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 12.69
A prostate cancer chromatin interaction map 12.69
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 12.69
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 12.69
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 12.69
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 12.62
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 12.57
Gene expression analysis of human liver progenitor-like cells in culture 12.44
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 12.38
Selective expression of long non-coding RNAs in a breast cancer cell progression model 12.38
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 12.36
CD95/Fas ligand mRNA is toxic to cells 12.32
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 12.27
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 12.27
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 12.14
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 12.14
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 12.08
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 12.05
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 11.91
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 11.89
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 11.77
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 11.64
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 11.63
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 11.63
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 11.62
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 11.6
Effect of BMP inhibition or stimulation of primary human keratinocytes 11.6
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 11.6
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 11.59
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 11.56
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 11.47
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 11.39
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 11.36
Genome-wide analysis of Dengue virus 2 infected cells 11.33
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 11.28
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 11.26
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 11.22
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 10.98
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 10.96
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 10.87
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 10.86
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 10.86
IL-33 activates tumor stroma to promote intestinal polyposis 10.7
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 10.54
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 10.54
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 10.48
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 10.39
Expression profiling of etoposide-induced senescent cells 10.35
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 10.15
High-Throughput Kinetic Analysis of Fractional Killing 10.11
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 10.09
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 10.08
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 10.01
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 9.93
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 9.9
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 9.88
9.86
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 9.8
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 9.76
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 9.68
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 9.66
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 9.64
Characterization of the Merkel cell carcinoma miRNome 9.55
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 9.38
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 9.34
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 9.26
Illumina Total RNA-seq in HeLa 9.24
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 9.12
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 9.12
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 9.12
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 8.89
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.83
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 8.75
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 8.75
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 8.71
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 8.67
mRNA differential expression analysis in a human ex vivo model of chronic wounds 8.65
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 8.61
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 8.59
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 8.5
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 8.5
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 8.44
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 8.44
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 8.44
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 8.44
iPSC-Derived Cholangiocytes 8.42
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 8.32
Transcriptomic analysis of ERR alpha orphan nuclear receptor 8.3
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 8.14
The evolution of N6-methyladenosine in primates 8.14
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 8.03
Functional Haploid Human Oocytes Generated from Polar Body Genomes 8.03
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 8.03
circNFIB suppresses lymphatic metastasis of pancreatic cancer 7.99
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 7.87
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 7.87
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 7.87
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 7.75
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 7.66
RNA-Seq of Breast and Ovarian Cancer Cell Lines 7.61
ARID1A and ARID1B loss in HCT116 and TOV21G cells 7.56
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 7.55
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 7.54
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 7.5
The role of the Calcium-Sensing receptor in colorectal cancer 7.48
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 7.4
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 7.26
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 7.2
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 7.11
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 7.06
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 7.03
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 6.97
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 6.91
Transcriptome of EBV-infected gastric cancer cell lines 6.9
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 6.8
RNA-seq analysis and shRNA screen of breast cancer 6.73
RNA-seq analysis of breast cancer 6.73
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 6.64
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.53
Gene expression analysis in response to hypoxic pathway inhibition 6.49
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 6.26
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 5.98
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 5.94
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 5.94
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 5.93
RNA-seq in endometrial stromal tumors 5.77
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 5.75
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.65
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 5.6
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.58
Transcriptome analysis of kidney organoids 5.56
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.53
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 5.49
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.45
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 5.45
Direct Isolation and Characterization of Human Nephron Progenitors. 5.33
Transcriptome wide analysis of classically and alternatively activated macrophages 5.27
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 5.25
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 5.05
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 4.92
Fusion discovery in breast cancer cell line 4.9
Transcriptomic profiling of human peripheral blood-derived mast cells 4.83
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 4.83
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 4.8
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 4.8
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 4.65
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.58
Gene expression of collecting duct carcinoma of the kidney 4.35
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.22
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 4.15
Identification of the role of polydom in neurofibromas 3.95
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 3.9
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 3.9
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 3.89
Finding missing proteins from epigenetically manipulated human cells 3.79
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.76
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 3.65
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 3.57
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 3.57
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 3.54
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.21
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.21
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.08
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 3.07
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.07
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.07
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.9
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 2.87
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 2.85
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.84
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.84
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 2.83
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.75
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 2.63
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 2.63
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 2.56
RNA Seq of HMVEC under hypoxia 2.55
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 2.55
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 2.2
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 2.15
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.14
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.12
The Genomic Landscape of Atypical Fibroxanthoma 2.05
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.88
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 1.86
RNA-seq of IL-4 stimulated human keratinocytes 1.81
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.71
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.69
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.67
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.52
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 1.43
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 1.41
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.26
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.24
Gene expression of thyroid cancer cell lines 1.2
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 1.1
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.83
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.83
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.7
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.5
Gene expression profile in breast cancer cell lines using RNA sequencing 0.48
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 0.48
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.48
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.43
Gene expression analysis of breast cancer cell-lines 0.42
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.42
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.28
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.27
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.27
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 0.24
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 0.24
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 0.19
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.16
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.01
Functional astrocytes differentiated from hiPSCs 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation